0001209191-11-023717.txt : 20110420
0001209191-11-023717.hdr.sgml : 20110420
20110420171302
ACCESSION NUMBER: 0001209191-11-023717
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110419
FILED AS OF DATE: 20110420
DATE AS OF CHANGE: 20110420
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gillespie Deirdre
CENTRAL INDEX KEY: 0001354737
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24274
FILM NUMBER: 11771327
MAIL ADDRESS:
STREET 1: 416 MARLBOROUGH STREET
STREET 2: APT. 707
CITY: BOSTON
STATE: MA
ZIP: 02115
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO
CENTRAL INDEX KEY: 0000920465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330361285
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4365 EXECUTIVE DRIVE, SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8584526600
MAIL ADDRESS:
STREET 1: 4365 EXECUTIVE DRIVE, SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0303
4
2011-04-19
0
0000920465
LA JOLLA PHARMACEUTICAL CO
LJPC
0001354737
Gillespie Deirdre
4365 EXECUTIVE DRIVE, SUITE 300
SAN DIEGO
CA
92121
1
1
0
0
President & CEO
Common Stock
2011-04-19
4
S
0
4376
0.70
D
0
D
/s/ Deirdre Y. Gillespie
2011-04-20